Chinese Traditional and Herbal Drugs
|
2025, 56(7): 2604-2616
Research progress on traditional Chinese medicine polysaccharides against chronic obstructive pulmonary disease
Full
LI Yong1, ZHAO Anhui1, BIAN Zhiying1, FANG Jiawei2, RUAN Yi2, TIAN Wenjing1, LIU Sijing2, GUO Jinlin1,2
Affiliations
1 School of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;
2 College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
doi: 10.7501/j.issn.0253-2670.2025.07.033
Outline
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, making the effective treatment of this condition is an urgent medical challenge. Polysaccharides derived from traditional Chinese medicine (TCM) have gained significant attention in COPD therapy due to their immunomodulatory, anti-inflammatory, and antioxidant properties. This study conducted a systematic search of databases, including PubMed, CNKI, and Web of Science, to summarize, categorize, and synthesize clinical trials and preclinical research on the use of these polysaccharides for the treatment of COPD over the past two decades. The analysis indicated that TCM polysaccharides, such as astragalus polysaccharides, lentinan and polysaccharide of Shihu (Dendrobii Caulis), can significantly improve clinical symptoms and respiratory function in COPD patients. These polysaccharides could enhance immune capacity and reduce inflammation levels. The mechanisms of action primarily involve alleviating oxidative stress, modulating immune-inflammatory responses, inhibiting airway remodeling, and regulating gut microbiota. The TCM polysaccharides in the treatment of COPD demonstrates substantial development potential and promising prospects. This not only broadens the application value of polysaccharides in traditional medicine but also provides a significant reference for the development and utilization of TCM polysaccharide resources and the discovery of new drugs for COPD.
traditional Chinese medicine polysaccharide
/
chronic obstructive pulmonary disease
/
clinical application
/
oxidative stress
/
immune-inflammation
/
airway remodeling
/
gut microbiota
/
astragalus polysaccharides
/
lentinan
/
polysaccharide of Dendrobii Caulis
李勇, 赵安慧, 边志影, 方佳伟, 阮燚, 田文静, 刘思静, 国锦琳.
中药多糖抗慢性阻塞性肺病的研究进展.
中草药,
2025
, 56
(7)
: 2604
-2616
.
DOI: 10.7501/j.issn.0253-2670.2025.07.033
LI Yong, ZHAO Anhui, BIAN Zhiying, FANG Jiawei, RUAN Yi, TIAN Wenjing, LIU Sijing, GUO Jinlin.
Research progress on traditional Chinese medicine polysaccharides against chronic obstructive pulmonary disease[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(7)
: 2604
-2616
.
DOI: 10.7501/j.issn.0253-2670.2025.07.033
Year 2025 volume 56 Issue 7
46
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.07.033
- Receive Date:2024-10-30
- Online Date:2026-11-13